Abstract

The escalating prevalence of insulin resistance (IR) and type 2 diabetes mellitus (T2D) underscores the urgent need for improved early detection techniques and effective treatment strategies. In this context, our study presents a proteomic analysis of post-exercise skeletal muscle biopsies from individuals across a spectrum of glucose metabolism states: normal, prediabetes, and T2D. This enabled the identification of significant protein relationships indicative of each specific glycemic condition. Our investigation primarily leveraged the machine learning approach, employing the white-box algorithm relative evolutionary hierarchical analysis (REHA), to explore the impact of regulated, mixed mode exercise on skeletal muscle proteome in subjects with diverse glycemic status. This method aimed to advance the diagnosis of IR and T2D and elucidate the molecular pathways involved in its development and the response to exercise. Additionally, we used proteomics-specific statistical analysis to provide a comparative perspective, highlighting the nuanced differences identified by REHA. Validation of the REHA model with a comparable external dataset further demonstrated its efficacy in distinguishing between diverse proteomic profiles. Key metrics such as accuracy and the area under the ROC curve confirmed REHA’s capability to uncover novel molecular pathways and significant protein interactions, offering fresh insights into the effects of exercise on IR and T2D pathophysiology of skeletal muscle. The visualizations not only underscored significant proteins and their interactions but also showcased decision trees that effectively differentiate between various glycemic states, thereby enhancing our understanding of the biomolecular landscape of T2D.

Details

Title
Exploring protein relative relations in skeletal muscle proteomic analysis for insights into insulin resistance and type 2 diabetes
Author
Czajkowska, Anna 1 ; Czajkowski, Marcin 2 ; Szczerbinski, Lukasz 3 ; Jurczuk, Krzysztof 2 ; Reska, Daniel 2 ; Kwedlo, Wojciech 2 ; Kretowski, Marek 2 ; Zabielski, Piotr 4 ; Kretowski, Adam 5 

 Medical University of Bialystok, Clinical Research Centre, Białystok, Poland (GRID:grid.48324.39) (ISNI:0000000122482838); Medical University of Bialystok, Department of Medical Biology, Białystok, Poland (GRID:grid.48324.39) (ISNI:0000 0001 2248 2838) 
 Bialystok University of Technology, Faculty of Computer Science, Białystok, Poland (GRID:grid.446127.2) (ISNI:0000 0000 9787 2307) 
 Medical University of Bialystok, Clinical Research Centre, Białystok, Poland (GRID:grid.48324.39) (ISNI:0000000122482838); Medical University of Bialystok, Department of Endocrinology, Diabetology and Internal Medicine, Białystok, Poland (GRID:grid.48324.39) (ISNI:0000 0001 2248 2838); Broad Institute of Harvard and MIT, Programs in Metabolism and Medical and Population Genetics, Cambridge, USA (GRID:grid.66859.34) (ISNI:0000 0004 0546 1623) 
 Medical University of Bialystok, Department of Medical Biology, Białystok, Poland (GRID:grid.48324.39) (ISNI:0000 0001 2248 2838) 
 Medical University of Bialystok, Clinical Research Centre, Białystok, Poland (GRID:grid.48324.39) (ISNI:0000000122482838); Medical University of Bialystok, Department of Endocrinology, Diabetology and Internal Medicine, Białystok, Poland (GRID:grid.48324.39) (ISNI:0000 0001 2248 2838) 
Pages
17631
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3086478179
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.